CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
107 hedge funds and large institutions have $3.27B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 14 closing their positions.
Holders
107
Holders Change
+1
Holders Change %
+0.94%
% of All Funds
1.81%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
51
Reduced
23
Closed
14
Calls
$14.2M
Puts
$10.3M
Net Calls
+$3.9M
Net Calls Change
-$271K
Top Buyers
1 |
1
BlackRock
New York
|
$109M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$12.3M |
3 |
HRCM
3
Hood River Capital Management
Palm Beach Gardens,
Florida
|
$11.2M |
4 |
4
Morgan Stanley
New York
|
$10.2M |
5 |
5
Lord, Abbett & Co
Jersey City,
New Jersey
|
$26.5M |